# OnCo record hd10 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/hd10/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "hd10", "NCT00265018" ;
  schema:name "GHSG HD10"@en ;
  schema:alternateName "HD10"@en, "Reduced treatment intensity in early-stage Hodgkin lymphoma"@en ;
  schema:description "Halving the chemotherapy and cutting the radiation dose by a third worked just as well for early Hodgkin lymphoma with favourable features, and caused fewer side effects."@en ;
  schema:url <https://onco.cc/trials/hd10/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00265018>, <https://doi.org/10.1056/NEJMoa1000067> ;
  onco:status "positive" ;
  onco:tag "lymphoma-evidence" ;
  onco:phase "3" ;
  schema:startDate "1998-05" ;
  onco:cancers <https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/radiation/> ;
  onco:technologies <https://onco.cc/terms/radiotherapy/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/bleomycin/>, <https://onco.cc/drugs/vinblastine/>, <https://onco.cc/drugs/dacarbazine/> ;
  onco:companies <https://onco.cc/companies/ghsg/> ;
  onco:terms <https://onco.cc/terms/abvd-beacopp/> ;
  onco:trials <https://onco.cc/trials/hd16/>, <https://onco.cc/trials/eortc-h10/> ;
  onco:people <https://onco.cc/people/andreas-engert/>, <https://onco.cc/people/peter-borchmann/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-survivorship/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ghsg-hd10-reduced-intensity-early-hodgkin-nejm-2010/> .